OncoMed Pharmaceuticals Competitors and Similar CompaniesClear all
OncoMed Pharmaceuticals's competitors and similar companies include Corvus Pharmaceuticals, Spectrum Pharmaceuticals, NMS Group and Exonate.
 OncoMed Pharmaceuticals OncoMed Pharmaceuticals is a biotechnology company developing novel therapeutics for the treatment of cancer. |  Corvus Pharmaceuticals Corvus Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the development of novel, first-in-class agents that target the immune system to treat patients with cancer. |  Spectrum Pharmaceuticals Spectrum Pharmaceuticals is a biotechnology company developing drugs to treat oncology and hematology. |  NMS Group NMS Group (Nerviano Medical Sciences) is a company focused on the discovery and early development of oncology drugs. |  Exonate Exonate is a biopharmaceutical company with drug discovery programs in ophthalmology, oncology and pain. | |
Founding Date | Founding Date 2004 | Founding Date 2014 | Founding Date 2002 | Founding Date N/A | Founding Date 2013 |
Type | Type Subsidiary | Type Public | Type Public | Type Private | Type Private |
Tags | |||||
Locations | Locations Redwood City, US HQ | Locations Burlingame, US HQ | Locations Henderson, US HQ Irvine, US | Locations Nerviano, IT HQ | Locations Duxford, GB HQ |
Employees | Employees 2261% decrease | Employees 4911% decrease | Employees 14638% decrease | Employees 76 | Employees 15 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 556.1 m | Valuation ($) 211.4 m | Valuation ($) N/A | Valuation ($) N/A |
Financial | |||||
Revenue (est.) | Revenue (est.) $44.4m (FY, 2018) | Revenue (est.) N/A | Revenue (est.) $10.1m (FY, 2022) | Revenue (est.) N/A | Revenue (est.) N/A |
Net income | Net income ($8.1m) (FY, 2018) | Net income ($15.3m) (FY, 2025) | Net income ($75.4m) (FY, 2022) | Net income N/A | Net income N/A |
Funding | |||||
Total funding raised | Total funding raised $ 210.2m | Total funding raised N/A | Total funding raised $ 3m | Total funding raised N/A | Total funding raised $ 11.8m |
For sources of this data, please see the company profile
View Company Profiles
Corvus Pharmaceuticals
HQ
Burlingame, US
Employees
49↓ 11% decrease
Corvus Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the development of novel, first-in-class agents that target the immune system to treat patients with cancer.
View companySpectrum Pharmaceuticals
HQ
Henderson, US
Employees
146↓ 38% decrease
Spectrum Pharmaceuticals is a biotechnology company developing drugs to treat oncology and hematology.
View companyNMS Group
HQ
Nerviano, IT
Employees
76
NMS Group (Nerviano Medical Sciences) is a company focused on the discovery and early development of oncology drugs.
View companyExonate
HQ
Duxford, GB
Employees
15
Exonate is a biopharmaceutical company with drug discovery programs in ophthalmology, oncology and pain.
View company